The t(7;12) rearrangement involving ETV6 has been found in Bone-third of acute myeloid leukaemia in early childhood. 1, 2 In a proportion of these cases, the homeobox gene HLXB9 has been identified as the fusion partner at the transcript level. 3 In this study, we analyzed 10 paediatric patients with acute myeloid leukaemia. Of these, seven (patient nos. 1-7) carried a t(7;12)(q36;p13), whereas three patients (nos. 8-10) were used as controls as they lacked abnormalities of either chromosome 7 or 12 (see Table 1 ). Expression analysis was carried out on all patients to investigate the presence of the specific transcripts ETV6, HLXB9, NOM1, the HLXB9-ETV6 fusion and its reciprocal ETV6-HLXB9. Furthermore, all patients were studied for the presence of a possible NOM1-ETV6 fusion (for primers, see Supplementary Material). The expression data obtained by RT-PCR are reported in Figure 1 . The ETV6 gene was expressed in all patients (data not shown). The HLXB9 gene was expressed in all seven patients with the t(7;12) (patients nos. 1-7) and in one of the three patients without the t(7;12) (patient no. 10, Figure 1e ). The fusion transcript HLXB9-ETV6 was detected in four out of seven patients with the t(7;12) (patient nos. 1, 2, 5 and 7) and in none of the patients without the t(7;12) (patients nos. 8-10, Figures 1a and b) . There was no evidence for the presence of the reciprocal transcript ETV6-HLXB9 in any patient. The NOM1 gene was expressed in two t(7;12) patients (case nos. 1 and 2) and in one case without the t(7;12) (patient no. 10, Figure 1f ). There was no evidence for the presence of a possible fusion transcript NOM1-ETV6 in any of the analyzed patients.
A growing number of studies indicate that the higher-order chromatin arrangement is related to gene expression. 6 Alterations of the nuclear architecture, including localization and compaction of large DNA regions, their replication timing and the relative expression levels are emerging factors in human diseases, including cancer. 7 The aim of this study was to investigate whether the altered expression pattern of the HLXB9 gene would correspond to an altered radial nuclear location of the 7q36 fragment (containing HLXB9) translocated on the der(12). We designed a fluorescence in situ hybridization assay that uses combinations of probes specific for the 7q36 and 12p13 regions, and can differentiate the derivative chromosomes from the wild-type homologues in the interphase nuclei (see Figure 2 ). 
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Using an earlier-described procedure, 8 we localized the HLXB9 gene at the nuclear periphery (see Figure 3 , left part), a nuclear compartment largely composed of compact, and generally nonexpressed, chromatin. This peripheral localization was consistent in cells of healthy individuals and in leukaemic cells not harbouring the t(7;12). Our fluorescence in situ hybridization experiments on the t(7;12) cell nuclei showed a shift in the radial position of the translocated HLXB9 allele (in 7q36), from the nuclear periphery to a more internal nuclear location (compare 7t with 7n data in Figure 3) . The difference is statistically extremely significant (Po0.0001). However, the non-translocated HLXB9 allele maintained a peripheral location as observed in the controls (see 7n data in Figure 3) .
From our findings and earlier reports, 2 it is apparent that a position effect mechanism triggers the expression of HLXB9 in the t(7;12) leukaemias. However, this is the first study that correlates aberrant gene expression with altered gene positioning as a consequence of a specific chromosomal translocation. In this case, the radial nuclear position of HLXB9 is altered after juxtaposition to an actively transcribed region. The ETV6 gene, that is expressed ubiquitously, is normally localized in the inner portion of the nucleus (see Figure 3) . On the other hand, HLXB9, that is not transcriptionally active after the developmental stages of embryonic life, is normally localized toward the nuclear periphery. 8 We have shown here that the translocated HLXB9 locus is brought to a more internal position by its translocation partner ETV6 in t(7;12) leukaemic cells, in which the HLXB9 expression is activated.
The chromosome region that includes ETV6 is shown to be an active gene-rich area, suggesting that at least some of these genes may be upregulated by positive cis elements. This might mean that the juxtaposition of the HLXB9 gene to the downstream region of the ETV6 gene causes an ectopic interaction between active cis elements (known to be capable of acting over 1 In (c), the probe combination allows the visualization of the der(12) as a dual-colour signal, whereas the single green signal indicates the normal chromosome 7 and the single red signal indicates the normal chromosome 12. In (d), the probe combination allows the visualization of the der(7) as a dual-colour FISH signal, whereas the single red signal indicates the normal chromosome 12 and the single green signals indicate the normal chromosome 7 (slightly larger) and the der(12) (smaller, resulting from the split signal of the 148a4 probe, spanning the breakpoint in 7q36). Nuclei were counter-stained with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI). Scale bar: 2 mm. Figure 3 Radial nuclear location of the HLXB9 and ETV6 loci on normal and translocated chromosomes. The radial nuclear location of each locus was defined statistically by the median value (and relative confidence interval, CI) of the 2D nuclear location of the hybridization signals, according to an earlier-described procedure.
8 C1, C2 and Pt-8 have been used as controls for the study. C1, and C2 indicate healthy individuals and Pt-8 indicates a patient with leukaemia lacking the t(7;12) rearrangement (see Table 1 ). Pt-1, Pt-2, Pt-3 and Pt-4 indicate patients with leukaemia carrying the t(7;12) (see Table 1 ). The healthy controls have been investigated for the following loci: CF14 (mapping at 7q31), D12S158 (mapping at 12p13.3), HLXB9 (mapping at 7q36.3) and ETV6 (mapping at 12p13), whereas the leukaemic controls and the t(7;12) patients were studied for the HLXB9 and ETV6 loci only. 7n indicates the non-translocated HLXB9 allele; 12n indicates the normal ETV6 allele, 7t indicates the HLXB9 allele translocated onto the chromosome 12 and detected as a fusion signal 227e6/2G8, 12t indicates the telomeric end of the ETV6 allele detected as a fusion signal 148a4/179A6 (see Figure 2 ). Pt-4 was analyzed with the probe combination 227e6/2G8 only, because of the limited amount of cell material available. Median values 40.65 indicate peripheral loci, whereas median values o0.65 indicate internal loci. large distances) and the HLXB9 promoter, both derepressing and upregulating its transcription. Activation of the HLXB9 expression through cis elements could occur soon after breakage and reunion of the DNA filaments, with concurrent repositioning of the chromatin at the nuclear level. This would render certain areas of the genome more exposed to the transcription machinery, resulting in a stable overexpression of HLXB9. Further work will focus on the study of epigenetic modifications occurring in these translocation cases. This will aim to support the circumstantial evidence provided here for a position effect mechanism, and will also provide mechanistic information to complement our observations on nuclear positioning and gene expression.
